A drug industry trade organization has chosen the University of Maryland Baltimore County Technology Center for the site of a new training center.
The Parenteral Drug Association, which represents scientists working at drug manufacturers nationwide, says it expects to train about 600 members at the new institute during the first year and 1,200 in the second year.
The first classes are expected to be held in February.
Edmund Fry, president of the Bethesda-based association, said the group has agreed to lease about 11,000 square feet at UMBC's technology campus near Catonsville.
About half of that space is to be converted into a state-of-the-art laboratory for training, he said.
The association traditionally has held its two- and three-day training classes at hotel conference rooms and other facilities, but had sought a facility for laboratory-based training, Fry said.
"Scientists from pharmaceutical companies around the country, indeed the world, will be trained at the center," he said.
It's estimated by UMBC that the association will spend about $415,000 on improvements.
The Baltimore County Department of Economic Development and the state have agreed to jointly finance $330,000 of the costs. The association will pay that back at 7.5 percent over five years, UMBC said.
UMBC officials said the association will lease the space for more than $170,000 annually under a five-year contract.
Fry said the association selected the technology center after considering several other sites around the nation because of its proximity to its Bethesda headquarters and Baltimore-Washington International Airport.
The association also liked the fact that the technology center is near the pharmaceutical industry's major hubs in southern New Jersey, New York and Pennsylvania, Fry said.
Training at the institute will be provided by experts hired on contract in the fields of biochemistry, molecular biology, and the processing standards of the Food and Drug Administration.
Pub Date: 8/05/96